Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M McKiernan

Showing results (1-10 of 230) with videos related to

Pageof 23
Sort By:
The Urologic Clinics of North America|November 24, 2019
Salvage Therapy Using Bacillus Calmette-Guérin Derivatives or Single Agent ChemotherapyChristopher R Haas, James M McKiernan
Current Opinion in Urology|August 10, 2004
Novel therapeutics in the treatment of bladder cancerJay B Shah, James M McKiernan
Reviews in Urology|June 8, 2007
High-risk, clinically localized prostate cancer: is monotherapy adequate?Mark H Katz, James M McKiernan
The Urologic Clinics of North America|May 9, 2007
Management of non-retroperitoneal residual germ cell tumor massesMark H Katz, James M McKiernan
World Journal of Urology|July 29, 2009
Reoperative retroperitoneal lymph-node dissection for testicular germ cell tumorAlana M Murphy, James M McKiernan
Cancer|July 22, 2014
Overtreatment of men with early-stage prostate cancer and limited life expectancyMatthew R Danzig, James M McKiernan
Urology|September 28, 2014
Reply: To PMID 25260447Solomon L Woldu, James M McKiernan
Current Opinion in Urology|December 9, 2004
Epidemiology of male osteoporosis and prostate cancerScott M Gilbert, James M McKiernan
The Urologic Clinics of North America|April 25, 2006
The role of bisphosphonates in preventing skeletal complications of hormonal therapyScott M Gilbert, James M McKiernan
The Urologic Clinics of North America|April 2, 2013
New agents for bacillus Calmette-Guérin-refractory bladder cancerJennifer J Ahn, James M McKiernan
Pageof 23

Showing results (1-10 of 230) with videos related to

Sort By:
Pageof 23
The Urologic Clinics of North America|November 24, 2019
Salvage Therapy Using Bacillus Calmette-Guérin Derivatives or Single Agent ChemotherapyChristopher R Haas, James M McKiernan
Current Opinion in Urology|August 10, 2004
Novel therapeutics in the treatment of bladder cancerJay B Shah, James M McKiernan
Reviews in Urology|June 8, 2007
High-risk, clinically localized prostate cancer: is monotherapy adequate?Mark H Katz, James M McKiernan
The Urologic Clinics of North America|May 9, 2007
Management of non-retroperitoneal residual germ cell tumor massesMark H Katz, James M McKiernan
World Journal of Urology|July 29, 2009
Reoperative retroperitoneal lymph-node dissection for testicular germ cell tumorAlana M Murphy, James M McKiernan
Cancer|July 22, 2014
Overtreatment of men with early-stage prostate cancer and limited life expectancyMatthew R Danzig, James M McKiernan
Urology|September 28, 2014
Reply: To PMID 25260447Solomon L Woldu, James M McKiernan
Current Opinion in Urology|December 9, 2004
Epidemiology of male osteoporosis and prostate cancerScott M Gilbert, James M McKiernan
The Urologic Clinics of North America|April 25, 2006
The role of bisphosphonates in preventing skeletal complications of hormonal therapyScott M Gilbert, James M McKiernan
The Urologic Clinics of North America|April 2, 2013
New agents for bacillus Calmette-Guérin-refractory bladder cancerJennifer J Ahn, James M McKiernan
Pageof 23